Given rises to six-month high as earnings beat estimates

Given rose to the highest level in six months after the Israeli maker of pill size cameras to diagnosis digestive tract ailments reported quarterly sales and profit that surpassed estimates. Sales rose to $48.5 million from $44.9 million a year earlier, and the company reported earnings of 25 cents per share, ahead of the 21 cents that analysts had forecast. “We recommend that investors buy shares of Given following last night’s strong results,’’ wrote Bryan Brokmeier, an analyst at Maxim Group in New York.